Product Name | (E/Z)-Afatinib (Synonyms: (E/Z)-BIBW 2992; (S)-阿法替尼) |
---|---|
CAS | 439081-18-2 |
Formula | C24H25ClFN5O3 |
MW | 485.94 |
Appearance | White to off-white powder |
Storage condition | 4°C, protect from light |
Size | Availability | Price(USD) | VIP Price (USD) | Quantity | |
---|---|---|---|---|---|
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible. |
Product Name | (E/Z)-Afatinib (Synonyms: (E/Z)-BIBW 2992; (S)-阿法替尼) |
---|---|
CAS | 439081-18-2 |
Formula | C24H25ClFN5O3 |
MW | 485.94 |
Appearance | White to off-white powder |
Storage condition | 4°C, protect from light |
(E/Z)-Afatinib ((E/Z)-BIBW 2992) is the mixture of (E)-Afatinib and (Z)-Afatinib. Afatinib (HY-10261) is an irreversible inhibitor of EGFR, by irreversibly binding to their ATP binding site to block activation of EGFR, HER2, HER4, and EGFRvIII. Afatinib used in co-administration with Temozolomide (HY-17364), potently targeting to EGFRvIII-cMet signaling in glioblastoma cells.
Preclinical evaluation of afatinib (BIBW2992) in esophageal squamous cell carcinoma (ESCC).
Am J Cancer Res. 2015 Nov 15;5(12):3588-99.
PMID: 25436978 PMCID: PMC4322967 DOI: 10.18632/oncotarget.2647
Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.
PMID: 29465762 PMCID: PMC5891184 DOI: 10.1111/cas.13546
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models.
PMID: 18408761 PMCID: PMC2748240 DOI: 10.1038/onc.2008.109